NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

Rituximab生物相似藥的全球市場 (2020-2030年) :COVID-19的成長與變化

Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 977231
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 2-10個工作天內
價格
Rituximab生物相似藥的全球市場 (2020-2030年) :COVID-19的成長與變化 Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球Rituximab生物相似藥市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區、國家的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 Rituximab生物相似藥市場特徵

第3章 Rituximab生物相似藥的市場規模、成長率

  • 全球市場的成果 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素
  • 全球市場的預測 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素

第4章 Rituximab生物相似藥市場區隔

  • 世界市場區隔:各應用領域,成果與預測 (以金額為準)
    • 非何杰金氏淋巴瘤
    • 慢性淋巴性白血病
    • 類風濕性關節炎
    • 其他
  • 世界市場區隔:成果與預測 (以金額為準)
    • 醫院藥局
    • 線上藥局
    • 零售藥局
    • 其他直接流通管道

第5章 Rituximab生物相似藥市場:各地區、國家分析

  • 全球市場的區分:各地區,成果與預測 (以金額為準)
  • 全球市場的區分:各國,成果與預測 (以金額為準)

第6章 亞太地區的Rituximab生物相似藥市場

  • 市場概要
  • 市場區隔:各應用領域,成果與預測 (以金額為準)

第7章 中國的Rituximab生物相似藥市場

第8章 印度的Rituximab生物相似藥市場

第9章 日本的Rituximab生物相似藥市場

第10章 澳洲的Rituximab生物相似藥市場

第11章 印尼的Rituximab生物相似藥市場

第12章 韓國的Rituximab生物相似藥市場

第13章 西歐的Rituximab生物相似藥市場

第14章 英國的Rituximab生物相似藥市場

第15章 德國的Rituximab生物相似藥市場

第16章 法國的Rituximab生物相似藥市場

第17章 東歐的Rituximab生物相似藥市場

第18章 俄羅斯的Rituximab生物相似藥市場

第19章 北美的Rituximab生物相似藥市場

第20章 美國的Rituximab生物相似藥市場

第21章 南美的Rituximab生物相似藥市場

第22章 巴西的Rituximab生物相似藥市場

第23章 中東的Rituximab生物相似藥市場

第24章 非洲的Rituximab生物相似藥市場

第25章 市場競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Pfizer Inc.
    • Mylan Inc.
    • Amgen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Celltrion Healthcare Co.,Ltd.

第26章 主要的收購與合併

第27章 市場趨勢與策略

第28章 未來展望和潛在性分析

第29章 附錄

目錄

“Rituximab Biosimilars Global Market Report 2020-30: COVID 19 Growth and Change ”from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global rituximab biosimilars market.

This report focuses on rituximab biosimilars market which is experiencing strong growth. The report gives a guide to the rituximab biosimilars market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the rituximab biosimilars? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Rituximab Biosimilars market global report” from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider rituximab biosimilars market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The rituximab biosimilars market section of the report gives context. It compares the rituximab biosimilars market with other segments of the rituximab biosimilars market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, rituximab biosimilars indicators comparison.

Scope

Markets Covered:

  • 1) By Application: Non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Rheumatoid arthritis; Others
  • 2) Hospital Pharmacy: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy; Other Direct Distribution Channels
  • Companies Mentioned: Pfizer Inc.; Mylan Inc.; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Celltrion Healthcare Co.,Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Rituximab Biosimilars Market Characteristics

3. Rituximab Biosimilars Market Size And Growth

  • 3.1. Global Rituximab Biosimilars Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Rituximab Biosimilars Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Rituximab Biosimilars Market Segmentation

  • 4.1. Global Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Non-Hodgkin's lymphoma
  • Chronic Lymphocytic Leukemia
  • Rheumatoid arthritis
  • Others
  • 4.2. Global Rituximab Biosimilars Market, Segmentation Hospital Pharmacy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Other Direct Distribution Channels

5. Rituximab Biosimilars Market Regional And Country Analysis

  • 5.1. Global Rituximab Biosimilars Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Rituximab Biosimilars Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Rituximab Biosimilars Market

  • 6.1. Asia-Pacific Rituximab Biosimilars Market Overview
  • 6.2. Asia-Pacific Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Rituximab Biosimilars Market

  • 7.1. China Rituximab Biosimilars Market Overview
  • 7.2. China Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Rituximab Biosimilars Market

  • 8.1. India Rituximab Biosimilars Market Overview
  • 8.2. India Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Rituximab Biosimilars Market

  • 9.1. Japan Rituximab Biosimilars Market Overview
  • 9.2. Japan Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Rituximab Biosimilars Market

  • 10.1. Australia Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Rituximab Biosimilars Market

  • 11.1. Indonesia Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Rituximab Biosimilars Market

  • 12.1. South Korea Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Rituximab Biosimilars Market

  • 13.1. Western Europe Rituximab Biosimilars Market Overview
  • 13.2. Western Europe Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Rituximab Biosimilars Market

  • 14.1. UK Rituximab Biosimilars Market Overview
  • 14.2. UK Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Rituximab Biosimilars Market

  • 15.1. Germany Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Rituximab Biosimilars Market

  • 16.3. France Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Rituximab Biosimilars Market

  • 17.1. Eastern Europe Rituximab Biosimilars Market Overview
  • 17.2. Eastern Europe Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Rituximab Biosimilars Market

  • 18.1. Russia Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Rituximab Biosimilars Market

  • 19.1. North America Rituximab Biosimilars Market Overview
  • 19.2. North America Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Rituximab Biosimilars Market

  • 20.1. USA Rituximab Biosimilars Market Overview
  • 20.2. USA Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Rituximab Biosimilars Market

  • 21.1. South America Rituximab Biosimilars Market Overview
  • 21.2. South America Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Rituximab Biosimilars Market

  • 22.1. Brazil Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Rituximab Biosimilars Market

  • 23.1. Middle East Rituximab Biosimilars Market Overview
  • 23.2. Middle East Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Rituximab Biosimilars Market

  • 24.1. Africa Rituximab Biosimilars Market Overview
  • 24.2. Africa Rituximab Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Rituximab Biosimilars Market Competitive Landscape And Company Profiles

  • 25.1. Rituximab Biosimilars Market Competitive Landscape
  • 25.2. Rituximab Biosimilars Market Company Profiles
    • 25.2.1. Pfizer Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Mylan Inc.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Amgen Inc.
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Teva Pharmaceutical Industries Ltd.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Celltrion Healthcare Co.,Ltd.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Rituximab Biosimilars Market

27. Rituximab Biosimilars Market Trends And Strategies

28. Rituximab Biosimilars Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer